Melanoma mystery

Melanoma mystery

Biological variability has confounded efforts to confirm the role of PREX2 mutations in melanoma.

Bibliographic Details
Main Author:	Roger J Davis
Format:	Article
Language:	English
Published:	eLife Sciences Publications Ltd 2017-01-01
Series:	eLife
Subjects:	Reproducibility Project: Cancer Biology replication metascience reproducibility driver mutation melanoma
Online Access:	https://elifesciences.org/articles/22662

Similar Items

Replication Study: Melanoma genome sequencing reveals frequent PREX2 mutations
by: Stephen K Horrigan, et al.
Published: (2017-01-01)

Replication Study: Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
by: Jeewon Kim, et al.
Published: (2018-12-01)

The challenges of replication
Published: (2017-01-01)

Making sense of replications
by: Brian A Nosek, et al.
Published: (2017-01-01)

Small molecules remain on target for c-Myc
by: Linchong Sun, et al.
Published: (2017-01-01)

Replication Study: Discovery and preclinical validation of drug indications using compendia of public gene expression data
by: Irawati Kandela, et al.
Published: (2017-01-01)

Mixed outcomes for computational predictions
by: Chi Van Dang
Published: (2017-01-01)

Replication Study: BET bromodomain inhibition as a therapeutic strategy to target c-Myc
by: Fraser Aird, et al.
Published: (2017-01-01)

Replication Study: Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
by: Xiaochuan Shan, et al.
Published: (2017-06-01)

Replication Study: Intestinal inflammation targets cancer-inducing activity of the microbiota
by: Kathryn Eaton, et al.
Published: (2018-10-01)

Replication Study: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs
by: Christine Mantis, et al.
Published: (2017-01-01)

Replication Study: The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
by: Stephen K Horrigan, et al.
Published: (2017-01-01)

Getting to grips with c-Myc
by: Dirk Eick
Published: (2018-01-01)

Replication Study: Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma
by: John Repass, et al.
Published: (2018-03-01)

Rethinking research into metastasis
by: Peter Friedl
Published: (2019-12-01)

The who, where and how of fusobacteria and colon cancer
by: Cynthia L Sears
Published: (2018-03-01)

Replication Study: Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis
by: Mee Rie Sheen, et al.
Published: (2019-12-01)

Replication Study: Transcriptional amplification in tumor cells with elevated c-Myc
by: L Michelle Lewis, et al.
Published: (2018-01-01)

Replication Study: The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate
by: Megan Reed Showalter, et al.
Published: (2017-06-01)

Replication Study: Wnt activity defines colon cancer stem cells and is regulated by the microenvironment
by: Anthony Essex, et al.
Published: (2019-06-01)

Replication Study: Systematic identification of genomic markers of drug sensitivity in cancer cells
by: John P Vanden Heuvel, et al.
Published: (2018-01-01)

Pseudogenes, RNAs and new reproducibility norms
by: George A Calin
Published: (2020-04-01)

Registered report: Melanoma genome sequencing reveals frequent PREX2 mutations
by: Denise Chroscinski, et al.
Published: (2014-12-01)

Replication Study: A coding-independent function of gene and pseudogene mRNAs regulates tumour biology
by: John Kerwin, et al.
Published: (2020-04-01)

Replication Study: The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
by: Xuefei Yan, et al.
Published: (2019-03-01)

The logical structure of experiments lays the foundation for a theory of reproducibility
by: Erkan O. Buzbas, et al.
Published: (2023-03-01)

Replication Study: Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs
by: Hongyan Wang, et al.
Published: (2020-10-01)

The Brazilian Reproducibility Initiative
by: Olavo B Amaral, et al.
Published: (2019-02-01)

Investigating the replicability of preclinical cancer biology
by: Timothy M Errington, et al.
Published: (2021-12-01)

An open investigation of the reproducibility of cancer biology research
by: Timothy M Errington, et al.
Published: (2014-12-01)

No relationship between researcher impact and replication effect: an analysis of five studies with 100 replications
by: John Protzko, et al.
Published: (2020-03-01)

Challenges for assessing replicability in preclinical cancer biology
by: Timothy M Errington, et al.
Published: (2021-12-01)

Time to do something about reproducibility
by: Sean J Morrison
Published: (2014-12-01)

What have we learned?
by: Peter Rodgers, et al.
Published: (2021-12-01)

Is preclinical research in cancer biology reproducible enough?
by: Patrick Bodilly Kane, et al.
Published: (2021-12-01)

Registered report: COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
by: Vidhu Sharma, et al.
Published: (2016-03-01)

Sharing the Recipe: Reproducibility and Replicability in Research Across Disciplines
by: Rima-Maria Rahal, et al.
Published: (2022-11-01)

The reproducibility debate is an opportunity, not a crisis
by: Marcus R. Munafò, et al.
Published: (2022-02-01)

Knowledge and Attitudes Among Life Scientists Toward Reproducibility Within Journal Articles: A Research Survey
by: Evanthia Kaimaklioti Samota, et al.
Published: (2021-06-01)

Replication Papers
by: Peter Harremoës
Published: (2019-07-01)